The key role of IL-7 in lymphopoiesis

Seminars in Immunology

Volumn 24, Issue 3, 2012, Pages 159-164

  Ceredig, Rhodri ^a   Rolink, Antonius G ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

B cell development; IL 7 and IL 7 signaling; T cell development

Indexed keywords

B LYMPHOCYTE RECEPTOR; INTERLEUKIN 7; TRANSCRIPTION FACTOR PAX5;

B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; GENE OVEREXPRESSION; HUMAN; INTRACELLULAR SIGNALING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; NONHUMAN; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; INTERLEUKIN-7; LYMPHOPOIESIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84861194903     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.02.004     Document Type: Review

References (77)

1. Namen A.E., Schmierer A.E., March C.J., Overell R.W., Park L.S., Urdal D.L., Mochizuki D.Y. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988, 167:988-1002.
2. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B., Meyer J.D., Davison B.L. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
3. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526.
4. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000, 1:426-432.
5. Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., Surh C.D. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001, 98:8732-8737.
6. Meier D., Bornmann C., Chappaz S., Schmutz S., Otten L.A., Ceredig R., Acha-Orbea H., Finke D. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 2007, 26:643-654.
7. Puel A., Ziegler S.F., Buckley R.H., Leonard W.J. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998, 20:394-397.
8. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., McBride O.W., Leonard W.J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147-157.
9. Rolink A., Grawunder U., Winkler T.H., Karasuyama H., Melchers F. IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol 1994, 6:1257-1264.
10. ten Boekel E., Melchers F., Rolink A. The status of Ig loci rearrangements in single cells from different stages of B cell development. Int Immunol 1995, 7:1013-1019.
11. Hardy R.R., Hayakawa K. B cell development pathways. Annu Rev Immunol 2001, 19:595-621.
12. Rolink A.G., Nutt S.L., Melchers F., Busslinger M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 1999, 401:603-606.
13. Nutt S.L., Heavey B., Rolink A.G., Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999, 401:556-562.
14. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol 2004, 22:55-79.
15. - hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur J Immunol 2005, 35:2019-2030.
16. Mandel E.M., Grosschedl R. Transcription control of early B cell differentiation. Curr Opin Immunol 2010, 22:161-167.
17. O'Riordan M., Grosschedl R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 1999, 11:21-31.
18. Rolink A.G., Winkler T., Melchers F., Andersson J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med 2000, 191:23-32.
19. Thompson E.C., Cobb B.S., Sabbattini P., Meixlsperger S., Parelho V., Liberg D., Taylor B., Dillon N., Georgopoulos K., Jumaa H., Smale S.T., Fisher A.G., Merkenschlager M. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 2007, 26:335-344.
20. Rolink A.G., Andersson J., Melchers F. Molecular mechanisms guiding late stages of B-cell development. Immunol Rev 2004, 197:41-50.
21. Tussiwand R., Bosco N., Ceredig R., Rolink A.G. Tolerance checkpoints in B-cell development: Johnny B good. Eur J Immunol 2009, 39:2317-2324.
22. Tsapogas P., Zandi S., Ahsberg J., Zetterblad J., Welinder E., Jonsson J.I., Mansson R., Qian H., Sigvardsson M. IL-7 mediates Ebf-1-dependent lineage restriction in early lymphoid progenitors. Blood 2011, 118:1283-1290.
23. Mikkola I., Heavey B., Horcher M., Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science 2002, 297:110-113.
24. Malin S., McManus S., Cobaleda C., Novatchkova M., Delogu A., Bouillet P., Strasser A., Busslinger M. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 2010, 11:171-179.
25. Malin S., McManus S., Busslinger M. STAT5 in B cell development and leukemia. Curr Opin Immunol 2010, 22:168-176.
26. Mandal M., Powers S.E., Maienschein-Cline M., Bartom E.T., Hamel K.M., Kee B.L., Dinner A.R., Clark M.R. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat Immunol 2011.
27. Hayakawa K., Hardy R.R. Development and function of B-1 cells. Curr Opin Immunol 2000, 12:346-353.
28. Hardy R.R., Kincade P.W., Dorshkind K. The protean nature of cells in the B lymphocyte lineage. Immunity 2007, 26:703-714.
29. + stage. Eur J Immunol 2004, 34:2647-2655.
30. Milne C.D., Paige C.J. IL-7: a key regulator of B lymphopoiesis. Semin Immunol 2006, 18:20-30.
31. Schwarz B.A., Sambandam A., Maillard I., Harman B.C., Love P.E., Bhandoola A. Selective thymus settling regulated by cytokine and chemokine receptors. J Immunol 2007, 178:2008-2017.
32. Brown G., Hughes P.J., Michell R.H., Rolink A.G., Ceredig R. The sequential determination model of hematopoiesis. Trends Immunol 2007, 28:442-448.
33. Love P.E., Bhandoola A. Signal integration and crosstalk during thymocyte migration and emigration. Nat Rev Immunol 2011, 11:469-477.
34. Ceredig R., Rolink T. A positive look at double-negative thymocytes. Nat Rev Immunol 2002, 2:888-897.
35. Godfrey D.I., Zlotnik A. Control points in early T-cell development. Immunol Today 1993, 14:547-553.
36. Ceredig R., Bosco N., Rolink A.G. The B lineage potential of thymus settling progenitors is critically dependent on mouse age. Eur J Immunol 2007, 37:830-837.
37. Sambandam A., Maillard I., Zediak V.P., Xu L., Gerstein R.M., Aster J.C., Pear W.S., Bhandoola A. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 2005, 6:663-670.
38. Balciunaite G., Ceredig R., Fehling H.J., Zuniga-Pflucker J.C., Rolink A.G. The role of Notch and IL-7 signaling in early thymocyte proliferation and differentiation. Eur J Immunol 2005, 35:1292-1300.
39. Fehling H.J., Gilfillan S., Ceredig R. Alpha beta/gamma delta lineage commitment in the thymus of normal and genetically manipulated mice. Adv Immunol 1999, 71:1-76.
40. Kisielow J., Tortola L., Weber J., Karjalainen K., Kopf M. Evidence for the divergence of innate and adaptive T-cell precursors before commitment to the αβ and γδ lineages. Blood 2011.
41. Laurent J., Bosco N., Marche P.N., Ceredig R. New insights into the proliferation and differentiation of early mouse thymocytes. Int Immunol 2004, 16:1069-1080.
42. Zuniga-Pflucker J.C. T-cell development made simple. Nat Rev Immunol 2004, 4:67-72.
43. Tussiwand R., Engdahl C., Gehre N., Bosco N., Ceredig R., Rolink A.G. The preTCR-dependent DN3 to DP transition requires Notch signaling, is improved by CXCL12 signaling and is inhibited by IL-7 signaling. Eur J Immunol 2011, 41:3371-3380.
44. + thymocyte differentiation: T cell two-step. Nat Immunol 2010, 11:189-190.
45. Park J.H., Adoro S., Guinter T., Erman B., Alag A.S., Catalfamo M., Kimura M.Y., Cui Y., Lucas P.J., Gress R.E., Kubo M., Hennighausen L., Feigenbaum L., Singer A. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol 2010, 11:257-264.
46. Boyman O., Ramsey C., Kim D.M., Sprent J., Surh C.D. IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J Immunol 2008, 180:7265-7275.
47. Bosco N., Ceredig R., Rolink A. Transient decrease in interleukin-7 availability arrests B lymphopoiesis during pregnancy. Eur J Immunol 2008, 38:381-390.
48. Kondo M., Akashi K., Domen J., Sugamura K., Weissman I.L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 1997, 7:155-162.
49. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997, 89:1033-1041.
50. Maraskovsky E., O'Reilly L.A., Teepe M., Corcoran L.M., Peschon J.J., Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant RAG-1 KO mice. Cell 1997, 89:1011-1019.
51. Hirokawa S., Sato H., Kato I., Kudo A. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells. Eur J Immunol 2003, 33:1824-1829.
52. + B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 1994, 22:321-328.
53. Pandey A., Ozaki K., Baumann H., Levin S.D., Puel A., Farr A.G., Ziegler S.F., Leonard W.J., Lodish H.F. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000, 1:59-64.
54. Park L.S., Martin U., Garka K., Gliniak B., Di Santo J.P., Muller W., Largaespada D.A., Copeland N.G., Jenkins N.A., Farr A.G., Ziegler S.F., Morrissey P.J., Paxton R., Sims J.E. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000, 192:659-670.
55. + B cells in vitro and signals via a novel mechanism. J Immunol 1999, 162:677-683.
56. Isaksen D.E., Baumann H., Trobridge P.A., Farr A.G., Levin S.D., Ziegler S.F. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol 1999, 163:5971-5977.
57. Chappaz S., Flueck L., Farr A.G., Rolink A.G., Finke D. Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice. Blood 2007, 110:3862-3870.
58. + cells from (C57BL/6 x DBA/2)F1 mice. Int Immunol 1990, 2:869-877.
59. MacDonald H.R., Lees R.K. Programmed death of autoreactive thymocytes. Nature 1990, 343:642-644.
60. Ceredig R. Intrathymic proliferation of perinatal mouse alpha beta and gamma delta T cell receptor-expressing mature T cells. Int Immunol 1990, 2:859-867.
61. Whetton A.D., Bazill G.W., Dexter T.M. Haemopoietic cell growth factor mediates cell survival via its action on glucose transport. EMBO J 1984, 3:409-413.
62. Swainson L., Kinet S., Mongellaz C., Sourisseau M., Henriques T., Taylor N. IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. Blood 2007, 109:1034-1042.
63. Fisher A.G., Burdet C., Bunce C., Merkenschlager M., Ceredig R. Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential. Int Immunol 1995, 7:415-423.
64. Mertsching E., Burdet C., Ceredig R. IL-7 transgenic mice: analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro. Int Immunol 1995, 7:401-414.
65. Mertsching E., Grawunder U., Meyer V., Rolink T., Ceredig R. Phenotypic and functional analysis of B lymphopoiesis in interleukin-7-transgenic mice: expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen. Eur J Immunol 1996, 26:28-33.
66. Ceredig R., Bosco N., Marche P.N., Andersson J., Rolink A. In interleukin-7-transgenic mice, increasing B lymphopoiesis increases follicular but not marginal zone B cell numbers. Eur J Immunol 2003, 33:2567-2576.
67. Valenzona H.O., Pointer R., Ceredig R., Osmond D.G. Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis. Exp Hematol 1996, 24:1521-1529.
68. Ceredig R., Andersson J., Melchers F., Rolink A. Effect of deregulated IL-7 transgene expression on B lymphocyte development in mice expressing mutated pre-B cell receptors. Eur J Immunol 1999, 29:2797-2807.
69. Namen A.E., Lupton S., Hjerrild K., Wignall J., Mochizuki D.Y., Schmierer A., Mosley B., March C.J., Urdal D., Gillis S. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988, 333:571-573.
70. Ceredig R. The ontogeny of B cells in the thymus of normal, CD3 epsilon knockout (KO) RAG-2 KO and IL-7 transgenic mice. Int Immunol 2002, 14:87-99.
71. Zamisch M., Moore-Scott B., Su D.M., Lucas P.J., Manley N., Richie E.R. Ontogeny and regulation of IL-7-expressing thymic epithelial cells. J Immunol 2005, 174:60-67.
72. Borges-Almeida E., Milanez H.M., Vilela M.M., Cunha F.G., Abramczuk B.M., Reis-Alves S.C., Metze K., Lorand-Metze I. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infect Dis 2011, 11:38.
73. Kim G.Y., Hong C., Park J.H. Seeing is believing: illuminating the source of in vivo interleukin-7. Immune Netw 2011, 11:1-10.
74. Shalapour S., Deiser K., Sercan O., Tuckermann J., Minnich K., Willimsky G., Blankenstein T., Hammerling G.J., Arnold B., Schuler T. Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo. Eur J Immunol 2010, 40:2391-2400.
75. Parrish Y.K., Baez I., Milford T.A., Benitez A., Galloway N., Rogerio J.W., Sahakian E., Kagoda M., Huang G., Hao Q.L., Sevilla Y., Barsky L.W., Zielinska E., Price M.A., Wall N.R., Dovat S., Payne K.J. IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol 2009, 182:4255-4266.
76. Mackall C.L., Fry T.J., Gress R.E. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011, 11:330-342.
77. Walsh S.T. A biosensor study indicating that entropy, electrostatics, and receptor glycosylation drive the binding interaction between interleukin-7 and its receptor. Biochemistry 2010, 49:8766-8778.